News: Pfizer Inc (PFE)

PFE on New York Consolidated

29.37USD
29 Aug 2014
Price Change (% chg)

$-0.01 (-0.05%)
Prev Close
$29.38
Open
--
Day's High
--
Day's Low
--
Volume
8,430,677
Avg. Vol
23,102,591
52-wk High
$32.96
52-wk Low
$27.86

Search Stocks
Select another date:

Weaker healthcare stocks weigh on European equities

* Bid target AstraZeneca falls; CEO says "back to normal"

European equities dip as healthcare stocks weaken

* Bid target AstraZeneca falls; CEO says "back to normal"

Early data suggest Sanofi, Regeneron drug may halve heart risk

* Good news for new PCSK9 drug class but needs confirmation

FTSE inches higher, Tesco slumps after profit warning

LONDON, Aug 29 - Britain's top share index ended slightly higher on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks outpacing a sharp decline in retail stocks after another profit warning by Tesco .

Germany's Bayer to launch three new Xarelto trials

FRANKFURT - Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines.

FTSE steadies, Tesco slumps after profit warning

LONDON, Aug 29 - Britain's top share index steadied in cautious trading on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks offsetting weaker retailers after another profit warning by Tesco.

FTSE edges higher, stronger drugmakers outpace weak retailers

LONDON, Aug 29 - Britain's top share index edged higher in cautious trading on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks outpacing weaker retailers after another profit warning by Tesco .

UPDATE 1-AstraZeneca boosted by start of new cancer drug trial

* AstraZeneca shares up 2 percent (Adds sales forecasts, detail on competitors, latest shares)

Britain's FTSE creeps higher; Tesco slides on profit warning

LONDON, Aug 29 - British shares inched higher on Friday in cautious trade as investors awaited inflation figures for the euro zone which may shed light on the European Central Bank's next move, though shares in Tesco dropped sharply on the back of a profit warning.

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

Select another date:

Press Releases

Search Stocks